Immunity , Infection Diseases and Agents
The immune system orchestrates a potent defense that consists of the production of specific antibody molecules and lymphocytes capable of reacting with and inactivating foreign agents, either directly or indirectly through the involvement of molecular and cellular inflammatory processes. The human immune system is necessary for our survival in a world full of potentially dangerous microbes, and high impairment of even one arm of this method can predispose to severe, even life-threatening, infections. Infection happens when a pathogen invades body cells and reproduces. Infection will generally lead to an immune response. If the response is fast and effective, the infection will be eliminated or contained so quickly that the disease will not occur. Sometimes infection leads to disease that is marked by symptoms or evidence of illness. Disease may occur when immunity is low or impaired, when virulence of the pathogen (its ability to damage host cells) is high, and when the number of pathogens in the body is great.
Related Conference of Immunity , Infection Diseases and Agents
9th International Conference on Vaccines, Immunology and Clinical Trials
7th International conference on Vaccines, Vaccination and Immunization
Immunity , Infection Diseases and Agents Conference Speakers
Recommended Sessions
- Antibiotics, Antimicrobial & Chemotherapy
- Antimicrobial Pathogens : Alternative Approaches
- Antimicrobials
- Antimicrobiology in Epidemiology
- COVID 19 in Antimicrobial and Antibacterial Agents
- Global Spread of Viruses
- Immunity , Infection Diseases and Agents
- Microbial Immunology
- Microbial Physiology and Metabolism
- Microorganisms in Recent Drug Discovery
- Pharmaceutical microbiology
- Pharmalogical Consideration of Infectious Disease and Agents
- Vaccine and Vaccination
- Vaccines and Therapeutics
Related Journals
Are you interested in
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Animal & Plant Derived Vaccines - Vaccines-Immunization-2026 (France)
- Animal Models & Clinical Trials - Vaccines-Immunization-2026 (France)
- Antibodies: Engineering & Therapeutics - Vaccines-Immunization-2026 (France)
- Bioinformatics and AI in Vaccine Design - Vaccine Immunology 2026 (France)
- Cancer, Malaria & TB Vaccines - Vaccines-Immunization-2026 (France)
- Cellular Immunology & Latest Innovations - Vaccines-Immunization-2026 (France)
- Challenges in Vaccine Accessibility and Equity - Vaccine Immunology 2026 (France)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Clinical Vaccinology and Immunotherapy - Vaccine Immunology 2026 (France)
- Combination & Conjugate Vaccines - Vaccines-Immunization-2026 (France)
- Current Research & Future Challenges - Vaccines-Immunization-2026 (France)
- DNA & Synthetic Vaccines - Vaccines-Immunization-2026 (France)
- Emerging Infectious Diseases - Vaccine Immunology 2026 (France)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fish & Poultry Vaccines - Vaccines-Immunization-2026 (France)
- Future Directions in Vaccine Research - Vaccine Immunology 2026 (France)
- Geriatric Immunization - Vaccines-Immunization-2026 (France)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- Global Vaccination Strategies - Vaccine Immunology 2026 (France)
- HIV Vaccines - Vaccines-Immunization-2026 (France)
- Human Microbiome and Vaccines - Vaccine Immunology 2026 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2026 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2026 (France)
- Immunology and Immune System Innovations - Vaccine Immunology 2026 (France)
- Immunology of Infectious Diseases - Vaccine Immunology 2026 (France)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Immunotherapy and Vaccines for Non-Infectious Diseases - Vaccine Immunology 2026 (France)
- Immunotherapy in Cancer Treatment - Vaccine Immunology 2026 (France)
- Industry and Technology Innovations - Vaccine Immunology 2026 (France)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Maternal, Neonatal, and Geriatric Immunization - Vaccine Immunology 2026 (France)
- Microbiome-Targeted Vaccines - Vaccine Immunology 2026 (France)
- Nanotechnology and Advanced Delivery Systems - Vaccine Immunology 2026 (France)
- Nanotechnology in Vaccine Delivery - Vaccine Immunology 2026 (France)
- Next-Generation Vaccine Platforms - Vaccine Immunology 2026 (France)
- Novel Vaccine Platforms: mRNA, DNA, and Viral Vectors - Vaccine Immunology 2026 (France)
- One Health Approach to Vaccine Development - Vaccine Immunology 2026 (France)
- Paediatric Vaccination - Vaccines-Immunization-2026 (France)
- Pandemic Preparedness and Response - Vaccine Immunology 2026 (France)
- Public Health and Global Immunization - Vaccine Immunology 2026 (France)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- The Economics of Vaccination - Vaccine Immunology 2026 (France)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Travel & Edible Vaccines - Vaccines-Immunization-2026 (France)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Trust - Vaccine Immunology 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Production & Development - Vaccines-Immunization-2026 (France)
- Vaccine Production and Global Supply Chains - Vaccine Immunology 2026 (France)
- Vaccine Research and Development - Vaccine Immunology 2026 (France)
- Vaccine Safety and Adverse Event Monitoring - Vaccine Immunology 2026 (France)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine Safety, Pharmacovigilance, and Adverse Event Monitoring - Vaccine Immunology 2026 (France)
- Vaccine-Induced Immunity and Duration of Protection - Vaccine Immunology 2026 (France)
- Vaccines - Vaccines-Immunization-2026 (France)
- Vaccines & Autism - Vaccines-Immunization-2026 (France)
- Vaccines against Drugs - Vaccines-Immunization-2026 (France)
- Vaccines against Infectious Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Immune Mediated Diseases - Vaccines-Immunization-2026 (France)
- Vaccines for Pregnant Women & Neonates - Vaccines-Immunization-2026 (France)
- Vaccines for Unconventional Diseases - Vaccines-Immunization-2026 (France)
- Vectors, Adjuvants & Delivery Systems - Vaccines-Immunization-2026 (France)
